Didier Debieuvre

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 07, 2026
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France.

|Nov 09, 2024
Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights.

Quentin Dominique Thomas, Nicolas Girard, Lise Bosquet

|Dec 23, 2022
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts.

Christos Chouaid, Michael Thomas, Didier Debieuvre

|Sep 07, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet

|Apr 28, 2020
A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer.

Clémence Legoupil, Didier Debieuvre, Aurelien Marabelle

|Nov 06, 2019
FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals.

Laurent Portel, Eric Parrat, Cécilia Nocent-Ejnaini

Pageof 1

Frequent Collaborators

2 joint publications

Lise Bosquet

2 joint publications

Christos Chouaid

1 joint publications

Clémence Legoupil

1 joint publications

Stefan Michiels